Estabrook Capital Management’s Zimmer Biomet ZBH Stock Holding History

Estabrook Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Hold	2,670	–	–	0.04%	113
2025 Q4	$240K	Hold	2,670	–	–	0.04%	114
2025 Q3	$263K	Hold	2,670	–	–	0.04%	111
2025 Q2	$244K	Sell	2,670 -10	-0.4%	-$967	0.04%	111
2025 Q1	$303K	Hold	2,680	–	–	0.05%	102
2024 Q4	$283K	Hold	2,680	–	–	0.04%	110
2024 Q3	$289K	Hold	2,680	–	–	0.04%	115
2024 Q2	$291K	Hold	2,680	–	–	0.04%	117
2024 Q1	$354K	Sell	2,680 -1,000	-27%	-$125K	0.05%	112
2023 Q4	$448K	Hold	3,680	–	–	0.07%	99
2023 Q3	$413K	Hold	3,680	–	–	0.07%	103
2023 Q2	$536K	Sell	3,680 -50	-1%	-$6.79K	0.09%	97
2023 Q1	$482K	Sell	3,730 -240	-6%	-$30.1K	0.08%	98
2022 Q4	$506K	Hold	3,970	–	–	0.09%	93
2022 Q3	$415K	Sell	3,970 -440	-10%	-$48.3K	0.08%	99
2022 Q2	$463K	Hold	4,410	–	–	0.08%	100
2022 Q1	$564K	Sell	4,410 -132	-3%	-$15.9K	0.08%	99
2021 Q4	$560K	Sell	4,542 -155	-3%	-$20.3K	0.08%	99
2021 Q3	$667K	Buy	4,697 +155	+3%	+$22.8K	0.11%	90
2021 Q2	$709K	Hold	4,542	–	–	0.11%	89
2021 Q1	$706K	Hold	4,542	–	–	0.11%	89
2020 Q4	$680K	Hold	4,542	–	–	0.11%	86
2020 Q3	$600K	Hold	4,542	–	–	0.11%	83
2020 Q2	$526K	Hold	4,542	–	–	0.1%	87
2020 Q1	$446K	Hold	4,542	–	–	0.09%	86
2019 Q4	$660K	Hold	4,542	–	–	0.1%	92
2019 Q3	$605K	Hold	4,542	–	–	0.1%	94
2019 Q2	$519K	Hold	4,542	–	–	0.09%	97
2019 Q1	$563K	Hold	4,542	–	–	0.09%	91
2018 Q4	$457K	Hold	4,542	–	–	0.08%	93
2018 Q3	$580K	Hold	4,542	–	–	0.09%	92
2018 Q2	$491K	Hold	4,542	–	–	0.08%	95
2018 Q1	$481K	Sell	4,542 -3	-0.1%	-$348	0.08%	100
2017 Q4	$533K	Hold	4,545	–	–	0.08%	96
2017 Q3	$517K	Hold	4,545	–	–	0.08%	96
2017 Q2	$567K	Hold	4,545	–	–	0.09%	97
2017 Q1	$539K	Hold	4,545	–	–	0.08%	97
2016 Q4	$455K	Hold	4,545	–	–	0.07%	103
2016 Q3	$574K	Sell	4,545 -2	-0%	-$247	0.08%	98
2016 Q2	$531K	Hold	4,547	–	–	0.08%	99
2016 Q1	$471K	Hold	4,547	–	–	0.07%	101
2015 Q4	$453K	Sell	4,547 -1,216	-21%	-$119K	0.07%	102
2015 Q3	$526K	Hold	5,763	–	–	0.08%	97
2015 Q2	$611K	Hold	5,763	–	–	0.08%	102
2015 Q1	$658K	Hold	5,763	–	–	0.08%	100
2014 Q4	$635K	Hold	5,763	–	–	0.07%	105
2014 Q3	$563K	Sell	5,763 -20	-0.3%	-$1.97K	0.06%	110
2014 Q2	$583K	Hold	5,783	–	–	0.06%	112
2014 Q1	$531K	Sell	5,783 -155	-3%	-$14.3K	0.05%	121
2013 Q4	$537K	Hold	5,938	–	–	0.06%	122
2013 Q3	$474K	Hold	5,938	–	–	0.05%	129
2013 Q2	$432K	Buy	+5,938	New	+$444K	0.05%	131

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Estabrook Capital Management's ZBH Position: Q1 2026 in Review

Estabrook Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 2,670 shares worth $241K. The position accounts for 0.04% of the portfolio, ranked #113.

Estabrook Capital Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $709K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Estabrook Capital Management held 2,670 shares of Zimmer Biomet worth $241K as of Q1 2026.
Estabrook Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
Zimmer Biomet made up 0.04% of Estabrook Capital Management's portfolio in Q1 2026, its #113 holding.
Estabrook Capital Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Estabrook Capital Management's Zimmer Biomet position peaked at $709K in Q2 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.